Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
about
How compensation breaks down in Parkinson's disease: Insights from modeling of denervated striatumLinear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.Dysphonic Voice Pattern Analysis of Patients in Parkinson's Disease Using Minimum Interclass Probability Risk Feature Selection and Bagging Ensemble Learning Methods.Relation between Voice Handicap Index (VHI) and disease severity in Iranian patients with Parkinson's diseaseThe safety issues and hardware-related complications of deep brain stimulation therapy: a single-center retrospective analysis of 478 patients with Parkinson's disease.Use of a self-rating scale of the nature and severity of symptoms in Parkinson's Disease (PRO-PD): Correlation with quality of life and existing scales of disease severity.Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.Recurrent Falls in People with Parkinson's Disease without Cognitive Impairment: Focusing on Modifiable Risk FactorsValidation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating Scale.Effect of Interpersonal Interaction on Festinating Gait Rehabilitation in Patients with Parkinson's Disease.Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's diseaseAssociations among Cognitive Functions, Plasma DNA, and White Matter Integrity in Patients with Early-Onset Parkinson's DiseaseAn economic model of Parkinson's disease: implications for slowing progression in the United States.Cerebral blood flow laterality derived from arterial spin labeling as a biomarker for assessing the disease severity of parkinson's disease.Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States.Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson's Disease Without a History of Falls: A One-Year Prospective Study.Estimating the lifetime economic burden of Parkinson's disease in Singapore.Experiences of caregivers of people with Parkinson's disease in Singapore: a qualitative analysis.Effects of various factors on sleep disorders and quality of life in Parkinson's disease.Comparison of Self-report and Performance-Based Balance Measures for Predicting Recurrent Falls in People With Parkinson Disease: Cohort Study.Validity and Reliability Study of the Korean Tinetti Mobility Test for Parkinson's Disease.Statistical Models of Parkinson's Disease Progression: Predictive Validity in a 3-Year Follow-up.Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study.Investigation of the Pharmaceutical Care in One Elderly Parkinson's Disease Patient with Psychotic Symptoms.The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease
P2860
Q28078491-5DFCFB70-5BD0-4E7D-9683-5F0267C33301Q30276531-4F48D11D-0DE4-42C0-9761-C45B0E0BD231Q30355655-92B4C1E8-B9ED-4AAC-B020-AEEFCB38A35DQ30457511-F8BD91D2-BC7D-43DC-B8B3-6404D654CA76Q33803724-F032AD12-F805-49FE-96C7-609052D00B5AQ33807815-687E8228-A2DA-47F1-94F0-981E70F0F12FQ34301607-6E8F6EC2-CDBE-471E-90A5-48BAEAC493B2Q34651698-2E0C6005-E66F-4FEE-B635-D04880B7911BQ35772039-DE3D4C7E-EF8E-4B57-AABB-B62870F97475Q36037830-E6B59057-FB97-4A98-BDAC-37D83EE8F11AQ37382891-0BDF252E-F3AA-4505-8140-A34CC2190E2CQ37491322-EB4EA60F-5FDC-4BB4-9A92-F84D3A8786EAQ37601377-8DD11519-BAD4-4AD4-95C2-494B785E5D34Q38081100-9DAB66C7-5D02-4A08-AA06-3A441EC3D8F0Q39328352-06668F8E-2299-4275-AE26-0A33EB8AD2A6Q39524073-DB89E6B0-FC32-4C55-9A20-17519748D015Q40016191-3262056E-A202-426A-A3B6-90395ED5C112Q40458623-BE10A36D-8A63-4207-B8BD-1FA44AC93A09Q44664066-9E25B813-1F3B-49F6-B954-1F89FAF8FD88Q47392450-AE765DCA-16BB-4927-A39D-DA7059514E14Q47975218-D595509D-F2B5-4AC8-BC1B-FBB8D5EA76B8Q48875510-0012E922-63CD-4545-863B-440D0609652FQ49269710-D4EC436E-C0AF-47B4-B1BB-A4EBCC20D58BQ50241406-DF84901B-D472-4223-A9C4-6255959C75BCQ50640051-C649A66B-4A0F-4F9E-8C0D-16B414B471C8Q55002124-14554384-47F6-448D-A8D4-BACEF3279317Q58566132-66A1D229-43B7-49FC-9529-09B145C1A52A
P2860
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@ast
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@en
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@nl
type
label
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@ast
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@en
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@nl
prefLabel
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@ast
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@en
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@nl
P2093
P2860
P3181
P356
P1433
P1476
Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
@en
P2093
Emmanuel Camara Pica
Louis C S Tan
Puay Ngoh Lau
Shu Chuen Li
Soo Hoon Seah
Wing Lok Au
Ying Jiao Zhao
Yiong-Huak Chan
P2860
P3181
P356
10.1002/MDS.22875
P407
P50
P577
2010-04-30T00:00:00Z